Friday, November 17, 2017 7:02:57 PM
I Have Speculated For Quite Some Time That The Entity That Is Doing A Licensing Deal With Pluristem, Also Wants To Buy A Stake In The Company Say 10-15% ? If That Is The Case, It Would Be In Their Best Interest To Keep The PPS Low, So.. Say A 50 Million Dollar Investment Gives Them More Shares Then If The Price Was Higher. Just Plain Logic.. Lower Price Equals More Shares For Them, Higher Price Equals Less Shares. That's My Thinking And I'm Sticking With It Until Proven Otherwise." This is saying "the entity" is keeping the price low...BTW, why in the world would PSTI, with their millions of personal shares Allo this?
Your words:
" I Agree 100 Percent Zzaatt....I Have Often Thought About That And Concluded: That Is Probably..Exactly What Pluristem Did Long Ago, They Walked Away Once They Found Out Who Is Behind The Stock Manipulation." If this was true, PSTI would be obligated to inform the SEC "they found out about stock price manipulation".
Your words:
" Which In-Turn, Left The Controlling Entity With Only One Choice. Continue To Keep The PPS Low Until Pluristem Releases
"Big News" That Would Surely Drive The Price Much Higher And Use That News As Cover To Buy Tens Of Millions Of Shares, Even taking The Price To $40.00 If Necessary, What-Ever it Takes To Buy 33.1 Percent Of The Company As That Gets You 2 Board Seats. Or If They Get Lucky They Are Able To Buy 51 Percent Of The Company And They Win The Prize ! Sounds Crazy..But Unfortunately, Some Big Pharma Knows A 400-800 Million Dollar Grab Of PSTI's Stock Could Turn Out To Be Worth 10 Billion In A Few Short Years. Food For Thought ! " Why in the world would PSTI management let an entity drive the stock price down? They have shares they want the price to go up.....maked no sense.
Which of your own words did I twist?
One last observation, statements like "Big news" are tell tale signs of a classic pump....
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM